Registered Members Login:
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

253 Pages (Click to Jump) V  < 1 2 3 4 5 > »    
Reply to this topic

post Posted: Dec 9 2015, 07:30 PM
  Quote Post

Posts: 53
Thanks: 20

In Reply To: plastic's post @ Dec 9 2015, 07:21 PM

That depends on your buy price. And seeing my average is less than 50 cents plus cost of capital over 8 years I'll take the risk. You maynot want to buy in at today's prices but good to see others are enthusiastic.

Good investing in other stocks - all the best and merry Xmas.

Said 'Thanks' for this post: chessen29  colindale  
post Posted: Dec 9 2015, 07:21 PM
  Quote Post

Posts: 9,499
Thanks: 285

$30m and still not worthy of a comment. Hate to be the one to say it, but I told you so. This is going down fast. First stop cash backing. Watch the cash burn then a RTO.

What did Uncle Mel do to us?
post Posted: Nov 24 2015, 05:57 AM
  Quote Post

Posts: 145
Thanks: 24

In Reply To: juxtaposer's post @ Nov 17 2015, 08:33 AM

Now I think they may have moved just above the "dead money" position.
Been watching all these months and last week bought a bit on this news. Let's see if they can follow through.

post Posted: Nov 17 2015, 08:33 AM
  Quote Post

Posts: 153
Thanks: 226

In Reply To: mercury's post @ Nov 17 2015, 06:11 AM

And this is a platform with multiple possibilities.
So many drugs can be attached and targeted. All the off patents and perhaps even some that failed to be passed but when delivered by dendrimer are now feasible.
Not to forget veterinary and agro-chemical applications.
Dow when they owned it had plans for lubricants and adheasives! Goodness knows why they let it go.
The potential seems extraordinary.

post Posted: Nov 17 2015, 06:11 AM
  Quote Post

Posts: 2,621
Thanks: 103

In Reply To: juxtaposer's post @ Nov 16 2015, 11:41 AM

this is very good news .... but one must realize that the 100% survival rate is limited (at this time) to 60 days.
Just the same, that is better than any other results from other companys' products.

I am no expert, but if this 60 days is extended to years, then this company's share are going to be worth much much more.

Holders will be thinking of this and one will see further announcements in the future regarding trials and results.

post Posted: Nov 16 2015, 04:38 PM
  Quote Post

Posts: 114
Thanks: 3

In Reply To: juxtaposer's post @ Nov 16 2015, 11:41 AM

Up 24% on the close

Share Cafe Sentifi Top themes and market attention on:

post Posted: Nov 16 2015, 11:41 AM
  Quote Post

Posts: 153
Thanks: 226

Melbourne, Australia; 16 November 2015:

Starpharma (ASX: SPL, OTCQX: SPHRY)
today announced that treatment with its novel antibody-targeted DEP
conjugate resulted in complete tumour regression and 100% survival in an ovarian cancer model.

post Posted: Sep 24 2015, 06:31 PM
  Quote Post

Posts: 2,379
Thanks: 263

Good one, SPL!


post Posted: Sep 11 2015, 12:16 PM
  Quote Post

Posts: 6

In Reply To: smarttogether's post @ Sep 10 2015, 08:09 AM

Another insider buy today. Peter Turvey bought 41 213 shares.

post Posted: Sep 10 2015, 08:09 AM
  Quote Post

Posts: 6

In Reply To: sh0950's post @ Sep 7 2015, 12:10 PM

More insider buying on Sept 9th - probably because of this.

Zita Peach: 13 888

Jacinth Fairley: 50 000

Rob Thomas: 50 000


253 Pages (Click to Jump) V  < 1 2 3 4 5 > » 

Back To Top Of Page
Reply to this topic

You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.